Gen-Probe to Webcast Presentation at Deutsche Bank Small- and Mid-Cap Growth ... (s we face and a discussion of ourfinanci...)

(Date:7/25/2008)...h Annual Physician On-Call Pay .../ -- Sullivan, Cotter and Associates, Inc.,has pub...ll pay rates and,practices, the 2008 Physician On-...ta from 132 healthcare organizations nationwide, o...paid for 33 physician specialty areas along,with d...

(Date:7/25/2008)...lusivity Begins -, CORONA, Calif., July 25 /PRNew...NYSE: WPI ), a leading specialty pharmaceutical,c...mmenced commercial,shipment of its Omeprazole Dela...gth from its Davie, Florida manufacturing facility...ays of marketing exclusivity for being the,first t...

(Date:7/25/2008)...ert J. Reilly, Joins Aethon Team, PITTSBURGH, Jul...on.com ), the leading developer of mobile robotics...ced that Robert J. Reilly has,joined the company a...., Reilly, who was most recently Vice President -...alty Pharmacy Division, brings more than 30,years ...

(Date:7/25/2008)...ekta Family of Companies will,showcase their uniqu...merican Association of Physicists in Medicine (AAP...ces of Elekta, IMPAC and CMS are delivering,cuttin...utions that,streamline the treatment process to cr...enhance clinician efficiency., "Our recent acquis...

Breaking Medicine News(10 mins):Health News:Hospital Expenditures for Physician On-Call Pay Rates Nearly Double 2 Health News:Hospital Expenditures for Physician On-Call Pay Rates Nearly Double 3 Health News:Watson Launches Omeprazole Delayed-Release Capsules, 40MG 2 Health News:Aethon, Inc. Names New Chief Financial Officer 2 Health News:Elekta Family of Companies to Highlight Cancer Treatment Solutions at 2008 AAPM Annual Meeting 2 Health News:Elekta Family of Companies to Highlight Cancer Treatment Solutions at 2008 AAPM Annual Meeting 3

[0] Hospital Expenditures for Physician On-Call Pay Rates Nearly Double [0] Watson Launches Omeprazole Delayed-Release Capsules, 40MG [0] Aethon, Inc. Names New Chief Financial Officer [0] Elekta Family of Companies to Highlight Cancer Treatment Solutions at 2008 AAPM Annual Meeting

...chers have discovered that a recently identified g...ighly aggressive form of the disease. These find...le blood test to predict who is susceptible to thi...esearchers said. Knowing which patients carry this...

...oped software that transforms a cellphone into a s...g lightning strike. A lightning bolt is an elect... producing frequencies between 10 hertz and five g...istribution of these signals depends on how far aw...

...oxic substance, made by certain types of bacteria ...ping the allergic skin condition eczema or wheezi... of 3. The toxic substance, Endotoxin is an eleme... bacteria, a type of bacteria that repeatedly caus...

..."Pound-for-Pound, The Most Powerful Weight-Loss Fo... screaming advertisements are common in many parts...e Canadians fall for them. But the concern is that... few regulations to govern this booming industry i...

Other Medicine News:Health News:Genetic Marker Linked to Aggressive Prostate Cancer 2 Health News:Beware Weight Loss Drugs, Say Canadian Experts 2 Health News:Beware Weight Loss Drugs, Say Canadian Experts 3 Health News:Beware Weight Loss Drugs, Say Canadian Experts 4

Genetic Marker Linked to Aggressive Prostate Cancer Now, Cellphones That Alert Against Impending Lightning Strikes Toxic Substance in House Dust may Reduce Eczema Risks in Early Life Beware Weight Loss Drugs, Say Canadian Experts

(Date:7/24/2008)...y 24 /- Ortho-McNeil Neurologics, a,d...nc., announced today,that the U.S. Food and Drug A...ity for TOPAMAX(R) (topiramate), based on studies ...FDA to investigate the use of TOPAMAX,in pediatric...eizures., In addition to granting pediatric exclu...

(Date:7/24/2008)..., July 24 /- Alexza,Pharmac...at it has initiated,its second Phase 3 clinical tr...an inhalation product candidate being developed fo...h schizophrenia or bipolar disorder.,Alexza believ...cokinetic,(PK) properties resulting from inhaled l...

(Date:7/24/2008)...PRNewswire-USNewswire/ -- Headlines claiming "soy,...story. The small scale,preliminary study that Dr....ction, is based on recollected intake of soyfoods ...is study is confounded by many,issues, thus I feel...,caution," warned Dr. Tammy Hedlund, a researcher ...

(Date:7/24/2008)...eter designed to take body temperature, for home,a...e-FirstCall/ --- Kidz-Med, Inc.,(subsidiary of Ame...,United States distributor of the Thermofocus(R) ...unce the results of a clinical study,conducted by ...Milan, in,Milan, Italy, which proves that the Ther...

Breaking Medicine Technology:FDA Grants Pediatric Exclusivity for TOPAMAX(R), Extending the Marketing Exclusivity by Six Months 2 FDA Grants Pediatric Exclusivity for TOPAMAX(R), Extending the Marketing Exclusivity by Six Months 3 Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 2 Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 3 Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 4 Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 5 Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 6 Soyfoods Do Not Impact Sperm Count 2 Pediatric Study Finds 21st Century Non-Contact Thermometer as Accurate as Conventional Thermometers 2 The Stay Strong Foundation Launches National Healing Starts With US Campaign With Celebrity Guests Denzel Washington Ruby Dee MoNique Terry McMilla 14367 1 The Stay Strong Foundation Launches National Healing Starts With US Campaign With Celebrity Guests Denzel Washington Ruby Dee MoNique Terry McMilla 14367 2 The Stay Strong Foundation Launches National Healing Starts With US Campaign With Celebrity Guests Denzel Washington Ruby Dee MoNique Terry McMilla 14367 3 30 National Organizations Issue Call to Action for Congress to Fully Fund Falls Prevention Programming in CDC Budget 14364 1 30 National Organizations Issue Call to Action for Congress to Fully Fund Falls Prevention Programming in CDC Budget 14364 2 30 National Organizations Issue Call to Action for Congress to Fully Fund Falls Prevention Programming in CDC Budget 14364 3 JCI online early table of contents 3A March 13 2008 14362 1 JCI online early table of contents 3A March 13 2008 14362 2 JCI online early table of contents 3A March 13 2008 14362 3 JCI online early table of contents 3A March 13 2008 14362 4 JCI online early table of contents 3A March 13 2008 14362 5 JCI online early table of contents 3A March 13 2008 14362 6 JCI online early table of contents 3A March 13 2008 14362 7 Lung Cancer Alliance Commends Leadership of MA State Senate 14360 1 Lung Cancer Alliance Commends Leadership of MA State Senate 14360 2

[0] FDA Grants Pediatric Exclusivity for TOPAMAX(R), Extending the Marketing Exclusivity by Six Months [0] Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine)[0] Soyfoods Do Not Impact Sperm Count [0] Pediatric Study Finds 21st Century Non-Contact Thermometer as Accurate as Conventional Thermometers

...DGEWATER, N.J., July 05, 2007 /PRNewswire/ -- Resu...trolled, open-label, Phase,3 study showed that 77 ...ults taking PREZISTA(TM) (darunavir) 600 mg tablet...plus an optimized,background regimen (OBR) of anti...ad of <400 copies/mL at week 48, compared to 68,pe...

...rst prospective biomarker trial in non-small cell ...ire-FirstCall/ -- Response,Genetics, Inc. today an...ished in the July 1 issue of the Journal of Clinic...omarker,Excision-Repair Cross-Complementing 1 (ERC...ell lung cancer (NSCLC) predicts for,sensitivity t...

Other Medicine Technology:New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 2 New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 3 New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 4 New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 5 New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 6 New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 7 New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 8 Response Genetics Announces Publication of a Phase III Clinical,Trial Demonstrating That Low Levels of ERCC-1 Help to Predict,Likelihood of Response to Cisplatin-Based Therapy in Lung Cancer 2 Response Genetics Announces Publication of a Phase III Clinical,Trial Demonstrating That Low Levels of ERCC-1 Help to Predict,Likelihood of Response to Cisplatin-Based Therapy in Lung Cancer 3 Response Genetics Announces Publication of a Phase III Clinical,Trial Demonstrating That Low Levels of ERCC-1 Help to Predict,Likelihood of Response to Cisplatin-Based Therapy in Lung Cancer 4

New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV Response Genetics Announces Publication of a Phase III Clinical,Trial Demonstrating That Low Levels of ERCC-1 Help to Predict,Likelihood of Response to Cisplatin-Based Therapy in Lung Cancer

The Libert Coronary Stent System introduces a new generation of lesion access and conformability. With exceptional flexibility, a low crossing profile, and the leading delivery catheter, the performa

..., and microplatesthat is the area of research in w...increasing force. Ergonomics (reduced weight and e...nel Research model was developed. This high-perfor... precise, and rapid processing of long series for ...

The Finnpipette Digital Multichannel, with it's streamlined design, makes even lighter work of routine laboratory tasks. The multichannel offers all these advanced features: Soft-touch tip ejection,

...mics, and value!, Comfortable feel and less hand ...er control while pipetting with smooth, light plun...long, lever tip ejector , Completely autoclavable ... the need for recalibration , Easy-to-read precisi...

Medicine Products:

Liberte™ Coronary Stent System Eppendorf Research Multichannel Pipette, 0.5-10 uL, 12-channel with adjustable volume setting, complete Finnpipette Digital Multichannel, 12 Channel 5-50ul SoftGrip 30-300 L x 12 Multi-Channel Pipette

Gen-Probe to Webcast Presentation at Deutsche Bank Small- and Mid-Cap Growth ...(s we face and a discussion of ourfinanci...),Health